FDA Inspection 1276636 — Colgate-Palmolive India Ltd.

Colgate-Palmolive India Ltd. — FEI 3004698222

The FDA completed an inspection of Colgate-Palmolive India Ltd. on July 25, 2025 in Mumbai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 25, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mumbai (India)

Citations

IDCFRDescription
192021 CFR 211.166(a)(3)Valid stability test methods